Since 1999, PELVIPHARM has had leading scientific and medical capabilities from its unique expertise and experience in pathophysiology, pharmacology, clinical research and medical practice across a range of therapeutic areas including urology (BPH, OAB, NDO, IC/PBS …), sexual medicine (ED, PE, FSD …), Women’s Health (Endometriosis/Dysmenorrhea, Vaginal Atrophy, PCOS, Uterine Fibroids …) and cardiometabolic disorders (Hypertension, Atherosclerosis, Diabetes …).